Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2017 August;69(4) > Minerva Urologica e Nefrologica 2017 August;69(4):400-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   

Minerva Urologica e Nefrologica 2017 August;69(4):400-7

DOI: 10.23736/S0393-2249.16.02663-1

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome

Tansu SAV 1 , Faruk CECEN 2, Enver S., ALBAYRAK 3

1 Department of Nephrology, Duzce University, Duzce, Turkey; 2 Department of Internal Medicine, Duzce University, Duzce, Turkey; 3 Department of Cardiology, Duzce University, Duzce, Turkey


PDF


BACKGROUND: Cardiorenal syndrome (CRS) is defined as complex pathophysiological disorder of the heart and kidneys. Both heart and renal failure are characterized by increased systemic oxidative stress in CRS. The aim of the present study is to assess the impacts of ultrafiltration (UF) and furosemide treatment on oxidative stress markers and renal functions in patients with CRS.
METHODS: In the study 77 patients with CRS (37 patients in the UF group and 40 patients in the furosemide group) were included. Plasma superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), glutathione peroxidase (GSH-Px) levels were studied in all patients on admission and at the end of the study.
RESULTS: Plasma SOD, CAT, MDA and GSH-Px levels did not show significant difference between the groups.
CONCLUSIONS: The effects of UF and furosemide therapies were similar on oxidative stress markers in patients with CRS. These methods safely decrease volume overload in a short-term period.


KEY WORDS: Cardio-renal syndrome - Oxidative stress - Renal insufficiency - Ultrafiltration

top of page